NSW Tuberculosis Surveillance Report 2025: Outcomes

​​​​​​​​​​​​​​​​​​​​​​​​​ On this page

  1. Outcomes for both multidrug-resistant (MDR) and non-MDR tuberculosis cases in NSW, 2024
  2. Contact investigation outcomes from tuberculosis pulmonary smear positive cases diagnosed in NSW, 2025

Outcomes for both multidrug-resistant (MDR)1 and non-MDR tuberculosis cases in ​​​NSW, 2024

The majority of TB cases successfully completed TB treatment in 2024 (86%). The treatment outcome is unable to be assessed when people transfer overseas (4% of cases), and a small number of cases die from causes not related to TB while on treatment (2% of cases).

Treatment outcomeNon-MDR casesMDR cases
Completed treatment446 (86%)4 (100%)
Lost to follow up or declined treatment
14 (3%)0 (0%)
​Treatment discontinued or not commenced on medical advice
9 (2%)​0 (0%)​
Treatment failure0 (0%)0 (0%)
Death related​ to TB15 (3%)0 (0%)
Died of other or unknown causes12 (2%) 0 (0%)
Transferred overseas to complete treatment22 (4%)0 (0%)
Remains on extensive treatment0 (0%)0 (0%)
Total518​​ (100%)
4 (100%)

Cont​​act investigation outcomes from TB pulmonary smear positive cases diagnosed in NSW, 2025​​​​2​ ​

There were 2017 contacts identified in NSW in 2025 from TB pulmonary smear positive cases, 68​​% of those completed contact screening for TB.

 

Notes

  1. Includes all MDR (multi-drug resistance), pre-XDR (pre-extensivel​y drug resistance), and XDR (extensively drug resistance) cases reported in 2024 (if applicable)​. 
  2. This reports on contacts tracing on the most infectious cases. More contact tracing was done but it is not reported here​​.​​

  3. Data for this report was extracted from Notifiable Conditions Records for Epidemiology and Surveillance, NSW Ministry of Health on 26 May 2026.

​
Current as at: Friday 12 June 2026
Contact page owner: Communicable Diseases